Erlotinib or Docetaxel for Second-Line Treatment of...

Erlotinib or Docetaxel for Second-Line Treatment of Non-small Cell Lung Cancer: A Real-World Cost-Effectiveness Analysis

Cromwell, Ian, van der Hoek, Kimberly, Melosky, Barbara, Peacock, Stuart
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1097/JTO.0b013e31822f657a
Date:
December, 2011
File:
PDF, 380 KB
english, 2011
Conversion to is in progress
Conversion to is failed